AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 617.00 Change Price %
High 623.50 1 Day 0.80 0.13
Low 608.40 1 Week -3.15 -0.51
Close 618.60 1 Month 47.00 8.22
Volume 1470307 1 Year -15.80 -2.49
52 Week High 809.45
52 Week Low 503.05
AUROPHARMA Important Levels
Resistance 2 632.60
Resistance 1 626.83
Pivot 616.83
Support 1 610.37
Support 2 604.60
NSE INDIA Most Active Stocks
JPASSOCIAT 20.40 -4.00%
NATIONALUM 86.05 -1.38%
RCOM 20.40 -1.92%
SUZLON 11.50 -1.71%
HINDALCO 262.10 -1.00%
GMRINFRA 19.50 -2.26%
ADANIPOWER 26.00 -0.57%
VISESHINFO 0.10 0.00%
PNB 93.60 -2.60%
YESBANK 308.55 -3.12%
More..
NSE INDIA Top Gainers Stocks
SKMEGGPROD 106.50 20.00%
KAKATCEM 315.50 19.98%
LEMONTREE 83.70 16.49%
WELSPUNIND 58.05 11.53%
HILTON 37.95 10.96%
KAYA 1203.15 10.07%
CYIENT 710.15 9.75%
BARTRONICS 11.35 9.66%
PRAKASHCON 8.00 9.59%
EXCELINDUS 1312.55 9.45%
More..
NSE INDIA Top Losers Stocks
FCSSOFT 0.30 -14.29%
RAJRAYON 0.30 -14.29%
EVEREADY 328.05 -10.60%
MONNETISPA 18.65 -9.90%
CALSOFT 29.15 -9.89%
BEDMUTHA 25.15 -9.86%
SMPL 1.05 -8.70%
RSSOFTWARE 53.50 -7.36%
SRSLTD 0.65 -7.14%
BILENERGY 0.65 -7.14%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 2
As on 20th Apr 2018 AUROPHARMA Share Price closed @ 618.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 670.71 & Strong Buy for SHORT-TERM with Stoploss of 596.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for April
1st Target up-side 603.58
2nd Target up-side 635.63
3rd Target up-side 667.68
1st Target down-side 512.12
2nd Target down-side 480.07
3rd Target down-side 448.02
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 58.54 Sideways
MFI (14) MFI is 67.97 Sideways
CCI (20) CCI is 67.75 Sideways
WILLIAM %R (14) William %R is Above -20 Over Bought
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 594.59
10 Day Avg Volume Traded -3.25 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.